Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Neoclone
company
About
Neoclone is a research-focused company with an emphasis on emerging antibody technologies.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $286.36K
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 1999
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Neoclone is a research-focused company with an emphasis on emerging antibody technologies. NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ways to discover and develop antibodies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.03M
Neoclone has raised a total of
$1.03M
in funding over 2 rounds. Their latest funding was raised on
Nov 1, 2012 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 1, 2012 | Grant | $286.36K | 1 |
National Institutes of Health
|
— | Detail |
| Jun 7, 2007 | Grant | $750K | 1 |
National Institutes of Health
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Neoclone has made 1 investments. Their most recent investment was on
Aug 22, 2013, when Tyba raised $1.31M.
Investors
Number of Lead Investors
Number of Investors
2
1
Neoclone is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
